When considering the additional impact of tau and its interactions in our models, we found that for proper name recall and Logical Memory total score, amyloid and tau statuses both may moderate the impact of PE, such that those who were positive for both biomarkers declined on proper name recall and Logical Memory total scores compared to those who were biomarker negative. The gene discussed is MAPT; the disease is amyloidosis.